MedPath

Motivational Interviewing and Guided Opioid Tapering Support to Promote Postoperative Opioid Cessation

Not Applicable
Completed
Conditions
Opioid Cessation
Interventions
Behavioral: Motivational Interviewing and Guided Opioid Tapering Support
Behavioral: Enhanced Usual Care
Registration Number
NCT03659734
Lead Sponsor
Stanford University
Brief Summary

The purpose of this study is to evaluate the relative efficacy of enhanced usual care versus motivational interviewing and guided opioid tapering support to promote opioid cessation after total hip or knee replacement surgery.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
179
Inclusion Criteria
  • Planning to undergo surgery
  • English speaking
  • Ability and willingness to complete questionnaires and assessments
  • Scheduled for total hip, knee, or shoulder replacement
  • Preoperative opioid use and opioid use 14 days after surgery to increase the likelihood of delayed opioid cessation.
  • Not under the care of a current pain management provider
Exclusion Criteria
  • Any conditions causing inability to complete assessments
  • Known pregnancy
  • Elevated suicidality
  • Enrollment in conflicting perioperative trial

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Motivational Interviewing and Guided Opioid Tapering SupportMotivational Interviewing and Guided Opioid Tapering Support-
Enhanced Usual CareEnhanced Usual Care-
Primary Outcome Measures
NameTimeMethod
Time to Opioid CessationThrough study completion, an average of 1 year

Time to opioid cessation between the two groups will be analyzed using survival analysis

Secondary Outcome Measures
NameTimeMethod
Number of Participants With Opioid Misuse (Postoperative COMM Score Greater Than or Equal to 9)Through study completion, 1 year after surgery

Assessed by total score on the Current Opioid Misuse Measure (COMM). The Current Opioid Misuse Measure is a self-report measure of risk for aberrant medication related behavior among persons who are prescribed opioids for pain. The COMM contains 17 items rated from 0="never" to 4="very often" . The 17 items are summed to create a total score with a minimum of 0 to a maximum of 68. Higher scores represent a higher risk of potential opioid medication misuse (worse outcome). Patients exhibiting opioid misuse (binary outcome) were defined as those reporting a postoperative COMM score greater than or equal to 9.

Trial Locations

Locations (1)

Stanford University School of Medicine

🇺🇸

Palo Alto, California, United States

© Copyright 2025. All Rights Reserved by MedPath